Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran
Brief: Bioxytran Completes Randomized Clinical Trial For Its Broad-Spectrum Antiviral Drug
Brief: Bioxytran Develops Groundbreaking Treatment To Combat Bird Flu In Egg Laying Chickens Potentially Saving Billions
Deals of the day-Mergers and acquisitions
Brief: Bioxytran’s Oral Antiviral Drug To Enter Dose Optimization Clinical Trial For Covid-19
Brief: Bioxytran Names Leslie Ajayi As Interim CMO, Head Of The Medical Advisory Board
China metals export curbs lift shares in US producer MP Materials (updated)
China rare earth curbs lift shares in U.S. producer MP Materials
China rare earth curbs lift shares in U.S. producer MP Materials
Brief: Bioxytran Expands Institutional Investor Base With $500,000 Equity Investment
Brief: Bioxytran Announces Positive Phase 2 Trial Results Were Featured In “Vaccines” A Peer-Reviewed Journal
Brief: Bioxytran Receives Approval to Begin Trials with ProLectin-I In India
MP Materials reports higher profit as rare earth prices surge (updated)
U.S. needs more mines to boost rare earths supply chain, Pentagon says
Reuters Next: For many, COVID-19 has changed the world of work for good
Brief: Bioxytran To Internally Develop Novel Carbohydrate Galectin Inhibitor To Eliminate Covid-19 In Patients